Occult hepatitis B virus among chronic liver disease patients in Yemen

Asian Pacific Journal of Tropical Disease

Volumn 2, Issue 1, 2012, Pages 4-6

  Thabit, A M ^a   Al Moyed, K A ^b   Al Balushi, M S ^c   Hasson, S S ^c   Sallam, T A ^d  

^a Military Hospital   (Yemen)

^b SANA A UNIVERSITY   (Yemen)

^c SULTAN QABOOS UNIVERSITY   (Oman)

^d AL BAHA UNIVERSITY   (Saudi Arabia)

Author keywords

Chronic liver disease; HBsAg; HBV DNA; Hepatitis B virus

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; CHRONIC LIVER DISEASE; FEMALE; HEPATITIS B; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YEMEN;

EID: 84856865424     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(12)60002-4     Document Type: Article

References (29)

1. Lavanchy D Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Viral Hepat 2004, 11(2):97-107.
2. Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, et al. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol 2008, 26(Suppl 48):S39-47.
3. Glebe D Recent advances in hepatitis B virus research: a German point of view. World J Gastroenterol 2007, 13(1):8-13.
4. Tandon BN, Acharya SK, Tandon A Epidemiology of hepatitis B virus infection in India. Gut 1996, 38(Suppl 2):S56-59.
5. Said ZN An overview of occult hepatitis B virus infection. World J Gastroenterol 2011, 17(15):1927-1938.
6. Ocana S, Casas ML, Buhigas I, Lledo JL Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol 2011, 17(12):1553-1557.
7. Wolff FH, Fuchs SC, Brandão AB Absence of occult hepatitis B among blood donors in southern Brazil. Braz J Infect Dis 2011, 15(2):159-162.
8. Raimondo G, Pollicino T, Cacciola I, Squadrito G Occult hepatitis B virus infection. J Hepatol 2007, 46(1):160-170.
9. Schmeltzer P, Sherman KE Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci 2010, 55(12):3328-3335.
10. Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, et al. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol 2007, 79:1075-1081.
11. Larrubia JR Occult hepatitis B virus infection: a complex entity with relevant clinical implications. World J Gastroenterol 2011, 17(12):1529-1530.
12. Miura Y, Shibuya A, Adachi S, Takeuchi A, Tsuchihashi T, Nakazawa T, et al. Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails. Hepatol Res 2008, 38:546-556.
13. Veropalumbo E, Marrone A, Vallefuoco L, Perruolo G, Orlando R, Scordino F, et al. Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays. Intervirol 2010, 53:183-187.
14. Selim HS, Abou-Donia HA, Taha HA, El Azab GI, Bakry AF Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes. Eur J Intern Med 2011, 22:187-190.
15. Sallam TA, Tong CYW Two distinct types of hepatitis B virus core promoter variants in Yemeni blood donors. J Med Virol 2002, 68:328-334.
16. Halima SB, Bahri O, Maamouri N, Cheikh I, Alaya NB, Sadraoui A, et al. Serological and molecular expression of Hepatitis B infection in patients with chronic hepatitis C from Tunisia, North Africa. Virol J 2010, 15:229.
17. Chakravarti A, Verma V, Jain M, Kar P Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital. Trop Gastroenterol 2005, 26:183-187.
18. Sheen IS, Liaw YF, Chu CM, Pao CC Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during hepatitis B virus infection. J Infect Dis 1992, 165:831-834.
19. Chu CM, Yeh CT, Sheen IS, Liaw YF Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV. Gut 2002, 51:95-99.
20. Liang HX, Chen YY, Zhou R, Zhang Q, Pan YF, Gu JS, et al. A cross-sectional survey of occult hepatitis B virus infection in HIV-infected patients in acquired immune deficiency syndrome area. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2010, 24(6):442-444.
21. Marque-Juillet S, Benghalia K, Monnier S, Fernand-Laurent C, Mazeron MC, Harzic M Should patients infected with HIV be screened for occult hepatitis B?. Pathol Biol (Paris) 2010, 58(2):e39-42.
22. Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol 2009, 81(3):441-445.
23. Schmeltzer P, Sherman KE Occult hepatitis B: clinical implications and treatme]][nt decisions. Dig Dis Sci 2010, 55(12):3328-3335.
24. Barth RE, Huijgen Q, Tempelman HA, Mudrikova T, Wensing AM, Hoepelman AIJ Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa. Med Virol 2011, 83:929-934.
25. Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Houspie L, Verbeeck J, Rahman M, et al. Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection. J Med Virol 2011, 83:1876-1884.
26. Al-Shamiri AH, Al-Taj MA, Ahmed AS Prevalence and co-infections of schistosomiasis/hepatitis B and C viruses among school children in an endemic areas in Taiz, Yemen. Asian Pac J Trop Med 2011, 4(5):404-408.
27. Aernan PT, Sar TT, Torkula SH Prevalence of plasmodia and hepatitis B virus co-infection in blood donors at Bishop Murray Medical Centre, Makurdi, Benue State, Nigeria. Asian Pac J Trop Med 2011, 4(3):224-226.
28. Abdel-Hady El-Gilany, Sabry Hammad, Khaled Refaat, Reda Al-Enazi Seroprevalence of hepatitis A antibodies among children in a Saudi community. Asian Pac J Trop Med 2010, 3(4):278-282.
29. Giannini E, Ceppa P, Botta F, Fasoli A, Romagnoli P, Ansaldi F, et al. Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients. Liver Int 2003, 23(1):12-18.